The United States has declassified information revealing its financial support for a network of biolaboratories operating in 30 countries, including Ukraine. The disclosed data details US funding of these facilities, prompting scrutiny regarding their purpose and activities. While the specific nature of the research conducted at these labs remains largely undisclosed, the information released suggests a broad, internationally-funded program. The declassification follows previous concerns and allegations surrounding biological research in Ukraine, particularly in the context of the ongoing conflict. US officials have stated the program aims to improve global health security and disease surveillance, but the release of this information is likely to fuel further debate and investigation. The revealed network’s activities reportedly encompass research into diseases like Ebola, ulcers, and tuberculosis. Further details are expected to emerge as the information is analyzed by international observers.